CR11315A - ANALYSIS OF INFECTIOUS DISEASES IN MONTHLY FLUID, ENDOMETRICAL / MONTHLY CELLS, AMNIOTIC FLUID, UMBILICAL CORDON BLOOD OR OTHER SAMPLES - Google Patents

ANALYSIS OF INFECTIOUS DISEASES IN MONTHLY FLUID, ENDOMETRICAL / MONTHLY CELLS, AMNIOTIC FLUID, UMBILICAL CORDON BLOOD OR OTHER SAMPLES

Info

Publication number
CR11315A
CR11315A CR11315A CR11315A CR11315A CR 11315 A CR11315 A CR 11315A CR 11315 A CR11315 A CR 11315A CR 11315 A CR11315 A CR 11315A CR 11315 A CR11315 A CR 11315A
Authority
CR
Costa Rica
Prior art keywords
fluid
monthly
test
sample
blood
Prior art date
Application number
CR11315A
Other languages
Spanish (es)
Inventor
Mercedes Walton
Julie G Allickson
Original Assignee
Cryo Cell Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cryo Cell Int filed Critical Cryo Cell Int
Publication of CR11315A publication Critical patent/CR11315A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se proveen metodos para obtener y probar o analizar una muestra de fluido humano o celular obtenida por puncion no venosa y no arterial, o fluido corporal o muestra celular humana para detectar la presencia de, al menos, una enfermedad infecciosa. La muestra puede ser fluido menstrual, celulas endometriales menstruales, sangre de cordon umbilical o fluido amniotico. Se puede realizar una prueba confirmatoria de una muestra de sangre arterial o venosa correspondiente para comparar con los resultados de la prueba para la muestra de fluido humano o muestra celular no venosa y no arterial. La prueba puede comprender una prueba de deteccion o prueba confirmatoria.Methods are provided to obtain and test or analyze a sample of human or cellular fluid obtained by non-venous and non-arterial puncture, or body fluid or human cell sample to detect the presence of at least one infectious disease. The sample can be menstrual fluid, menstrual endometrial cells, umbilical cord blood or amniotic fluid. A confirmatory test of a corresponding arterial or venous blood sample may be performed to compare with the test results for the human fluid sample or non-venous and non-arterial cell sample. The test may comprise a screening test or confirmatory test.

CR11315A 2007-09-14 2010-03-15 ANALYSIS OF INFECTIOUS DISEASES IN MONTHLY FLUID, ENDOMETRICAL / MONTHLY CELLS, AMNIOTIC FLUID, UMBILICAL CORDON BLOOD OR OTHER SAMPLES CR11315A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99374807P 2007-09-14 2007-09-14
US19160108P 2008-09-09 2008-09-09

Publications (1)

Publication Number Publication Date
CR11315A true CR11315A (en) 2010-08-13

Family

ID=40452371

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11315A CR11315A (en) 2007-09-14 2010-03-15 ANALYSIS OF INFECTIOUS DISEASES IN MONTHLY FLUID, ENDOMETRICAL / MONTHLY CELLS, AMNIOTIC FLUID, UMBILICAL CORDON BLOOD OR OTHER SAMPLES

Country Status (15)

Country Link
EP (1) EP2200620A4 (en)
JP (1) JP2010539479A (en)
KR (1) KR20100063089A (en)
CN (1) CN101854942A (en)
AR (1) AR068449A1 (en)
AU (1) AU2008299884A1 (en)
BR (1) BRPI0817333A2 (en)
CA (1) CA2699491A1 (en)
CL (1) CL2008002749A1 (en)
CR (1) CR11315A (en)
EC (1) ECSP10010048A (en)
MX (1) MX2010002910A (en)
NI (1) NI201000037A (en)
TW (1) TW200918020A (en)
WO (1) WO2009035706A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160146789A1 (en) * 2013-07-03 2016-05-26 Coyne Scientific, Llc Methods for Predicting Responses to Chemical or Biological Substances
BR112017002888A2 (en) 2014-08-12 2017-12-05 Nextgen Jane Inc system and method for health monitoring in body fluid collected
EP3442706A4 (en) 2016-04-13 2020-02-19 NextGen Jane, Inc. Sample collection and preservation devices, systems and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725481A (en) * 1996-05-17 1998-03-10 A. Fem Medical Corporation Method and apparatus for collecting vaginal fluid and exfoliated vaginal cells for diagnostic purposes
US7638093B2 (en) * 2004-01-28 2009-12-29 Dnt Scientific Research, Llc Interrupted flow rapid confirmatory immunological testing device and method
AR065584A1 (en) * 2007-03-01 2009-06-17 Cryo Cell Internat Inc OBTAINING INSULATION AND CRIOCONSERVATION OF ENDOMETRIC / MENSTRUAL CELL

Also Published As

Publication number Publication date
EP2200620A4 (en) 2010-10-27
CL2008002749A1 (en) 2010-05-07
CA2699491A1 (en) 2009-03-19
KR20100063089A (en) 2010-06-10
TW200918020A (en) 2009-05-01
CN101854942A (en) 2010-10-06
NI201000037A (en) 2011-06-21
BRPI0817333A2 (en) 2017-06-13
AR068449A1 (en) 2009-11-18
AU2008299884A1 (en) 2009-03-19
EP2200620A1 (en) 2010-06-30
JP2010539479A (en) 2010-12-16
MX2010002910A (en) 2010-05-24
ECSP10010048A (en) 2010-06-29
WO2009035706A1 (en) 2009-03-19

Similar Documents

Publication Publication Date Title
PA8796101A1 (en) ANALYSIS OF INFECTIOUS DISEASES IN MONTHLY FLUID, ENDOMETRIC / MONTHLY CELLS, AMNIOTIC FLUID, BLOOD OF UMBILICAL CORDON OR OTHER SAMPLES
BR112015026248A2 (en) biological fluid collection device and biological fluid separation and testing system
CR20110567A (en) DEVICES FOR DIAGNOSIS AND RELATED METHODS
WO2006091412A3 (en) Adamts-7 as a biomarker for cancers of epithelial origin
ES2656962T3 (en) Methods to assess the receptivity of a patient's endometrium
DE602005017519D1 (en) AUTOMATIC GLYCOFINGERPRINT STRATEGY
AR034376A1 (en) A SAMPLING AND MEASUREMENT DEVICE FOR CONCENTRATION OF BIOLOGICAL FLUID COMPONENTS
GB201209668D0 (en) Methods of monitoring conditions by sequence analysis
EP4306955A3 (en) Integrated functional and molecular profiling of cells
WO2006024466A3 (en) Test device for the in vitro diagnosis of multi-analyte tests and the use thereof
WO2008132753A3 (en) Methods and kits for detecting fetal cells in the maternal blood
BRPI0916624A2 (en) selective hepcidin-25 monoclonal antibodies, their uses, as well as method and kit for quantifying the amount of hepcidin-25 protein in a tissue or biological fluid sample
PE20141565A1 (en) METHODS TO DETECT HUMAN PAPILLOMAVIRUS AND PROVIDE PROGNOSIS FOR SCAMOUS CELL CARCINOMA OF THE HEAD AND NECK
CR11315A (en) ANALYSIS OF INFECTIOUS DISEASES IN MONTHLY FLUID, ENDOMETRICAL / MONTHLY CELLS, AMNIOTIC FLUID, UMBILICAL CORDON BLOOD OR OTHER SAMPLES
WO2007061988A3 (en) Methods for determining notch signaling and uses thereof
BR112015014232A2 (en) acute kidney injury
ATE550660T1 (en) DIAGNOSIS OF A DISEASE AND CLASSIFICATION OF CANCER USING MEMBRANE ELECTROPHORESIS
MX2009009114A (en) Test strip with integrated lancet.
WO2010133881A3 (en) Tissue analysis
WO2011019807A3 (en) Measurement of mitochondrial membrane potential to assess organ dysfunction
BR112014032278A2 (en) analytical test strip with capillary sample receiving chambers separated by stop junctions
ATE545027T1 (en) SAMPLE COLLECTION PROCEDURES
Connolly et al. Reverse iontophoresis: A new approach to measure blood glucose level
Sameera et al. Cytomorphometry as a Diagnostic Tool for Assessing the Altered Nature of Exfoliated Buccal Mucosal Cells in Diabetic and Hypertensive Patients.
RU2011101256A (en) METHOD FOR EVALUATING THE ADRENAL Bark FUNCTION

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)